-
Beyond CRISPR Cuts: Five Complements To Cas9
Bio-IT World | With the dominance of CRISPR/Cas9 gene-editing technology dominating headlines and genomics laboratories, gene therapy researchers are seeking new discoveries in gene-editing as relevant and useful alternatives to CRISPR.
Feb 22, 2017
-
Cambridge Research Biochemicals Launches Second Catalogue To The Life Science Community
Bio-IT World Brief | Cambridge Research Biochemicals today announced the release of its new DISCOVERY Antibodies catalogue.
Feb 21, 2017
-
China Biotech Makes Big Data A Weapon In Its War On Cancer
China Daily | China has made the precision medicine field a focus of its 13th Five-Year Plan, and its companies have been embarking on ambitious efforts to collect a trove of genetic and health data, researching how to identify cancer markers in blood, and launching consumer technologies that aim to tap potentially lifesaving information.
Feb 20, 2017
-
The New Offensive on Alzheimer’s Disease Stop it Before it Starts
Newsweek | No medicine has been able to slow the progression of the disease, so researchers are taking an aggressive new approach.
Feb 17, 2017
-
Data Conversations: Cycle, University of Arizona Researchers Model Strength Of The Cloud
Bio-IT World | When a University of Arizona researcher wanted to demonstrate the future of drug discovery for her students, she couldn’t do it on the local HPC cluster. She needed to do her experiment in the cloud.
Feb 17, 2017
-
HIPAA In 2017 Is Not Your Old HIPAA; It’s Grown Teeth
Bio-IT World Contributed Commentary | In 2017, Health and Human Services and the Office for Civil Rights are both working hard to ensure that cloud providers are aligned with HIPAA.
Feb 16, 2017
-
Broad Institute Prevails In Heated Dispute Over CRISPR Patents
STAT | In a one-sentence decision, the Patent Trial and Appeal Board ruled that key CRISPR patents awarded to the Broad Institute beginning in 2014 are sufficiently different from ones applied for by the University of California.
Feb 15, 2017
-
Human Gene Editing Receives Science Panel’s Support
The New York Times | Pressed by controversial, advancing technology, an influential committee laid out the conditions under which human embryos might be engineered with heritable traits.
Feb 14, 2017
-
Bionano Genomics Announces Global Launch Of Saphyr
Bio-IT World Brief | Bionano Genomics today announced the global commercial launch of Saphyr, its newest and most advanced system for genome mapping.
Feb 13, 2017
-
Illumina Welcomes New Startups To Its Accelerator Program
Bio-IT World Brief | Illumina announced today that it has chosen three new startups to join its accelerator program, which provides investment capital and other resources to early-stage companies developing new genomic technologies and applications.
Feb 10, 2017
-
A Call For Academic Drug Companies
In The Pipeline | Derek Lowe, in his blog for Science Translational Medicine, offers his thoughts on the question, "How Much Longer Will We Put Up With $100,000 Cancer Drugs?"
Feb 10, 2017
-
MyHeritage Announces Yaniv Erlich As New Chief Science Officer
Bio-IT World Brief | Yaniv Erlich is joining Israeli online genealogy platform company, MyHeritage, as Chief Science Officer.
Feb 9, 2017
-
Chan Zuckerberg Biohub Names Investigators, Builds Collaborative Culture
Bio-IT World The Chan Zuckerberg Biohub has named its first cohort of 47 investigators from the University of California, Berkeley, Stanford University and the University of California, San Francisco.
Feb 8, 2017
-
Align Biopharma Provides Easier Connection To Healthcare Professionals
Bio-IT World | Six technology leaders have come together to create Align Biopharma, a new industry standards group aiming to ease digital engagement challenges for member companies and their users.
Feb 8, 2017
-
FDA Proposal On Biotech Drugs Sparks Criticism
TheHill | The FDA wants to give biotech drugs more distinct names, but some drugmakers and agencies aren't on board.
Feb 7, 2017
-
Malin Announces Acquisition Of Artizan Biosciences Shareholdings
Bio-IT World Brief | Malin today announced that it has acquired a 32% shareholding of Artizan Biosciences.
Feb 6, 2017
-
Oxford Nanopore Responds To UK Pacific Biosciences Suit
Bio-IT World Brief | Pacific Biosciences has issued a patent lawsuit against Oxford Nanopore. Oxford Nanopore has released a statement addressing the suit.
Feb 3, 2017
-
Reproducibility Project Dismisses Landmark Cancer Studies Without Investigation
Bio-IT World Contributed Commentary | The Reproducibility Project recently published the results for its first five papers, leaving academic groups questioning the validity of the project.
Feb 3, 2017
-
NIH Expands Critical Catalog For Genomics Research
Bio-IT World Brief | The NIH plans to expand its ENCODE Project, a genomics resource used by many scientists to study human health and disease.
Feb 3, 2017
-
Mysterious $2 Billion Biotech Reveals Secrets Behind Its New Drugs And Vaccines
Science | AAAS | Moderna Therapeutics hopes to turn RNA into a new kind of drug. The question is whether or not it can live up to the hype.
Feb 2, 2017